| | | | |
CUSIP No. 8676EP108 | | 13D | | Page 14 of 14 Pages |
Amendment No. 10 to Schedule 13D
This Amendment No. 10 (“Amendment No. 10”) amends and supplements the Schedule 13D originally filed with the Securities and Exchange Commission on October 17, 2016, as amended by Amendment No. 1 through Amendment No. 9 (as so amended, the “Schedule 13D”). Except as set forth herein, the Schedule 13D remains in full force and effect. Each capitalized term used but not defined herein has the meaning ascribed to such term in the Schedule 13D.
Item 2. Identity and Background
Items 2(a) – (c) and (f) of the Schedule 13D are hereby amended and supplemented by the following:
With effect from December 9, 2022, Brookfield Asset Management Inc., an Ontario corporation, changed its name to Brookfield Corporation.
Item 5. Interest in Securities of the Issuer.
The information set forth in Item 5 of the Schedule 13D is amended as follows:
(a)– (c) The information relating to the beneficial ownership of the common stock by each of the Reporting Persons set forth in Rows 7 through 13 of the cover pages hereto is incorporated by reference herein and is as of the date hereof. Such beneficial ownership information is based on 115,419,623 shares of Common Stock outstanding as of May 5, 2023 as reported in the Issuer’s Form 10-Q, filed with the SEC on May 10, 2023 (the “10-Q”) and, except as otherwise noted, assumes the exchange of Series B-1 Preferred Stock beneficially owned by each Reporting Person, as applicable, into Common Shares (subject in all cases to the Series B-1 Exchange Caps to which the Oaktree Funds are subject, and described more fully in Item 5 of Amendment 6 to this Schedule 13D).
Subject to the Series B-1 Exchange Caps, the shares of Series B-1 Preferred Stock held by Organics and OHIF II LP are currently exchangeable into an aggregate of 2,451,242 and 481,211, respectively, of Common Shares. In absence of the Series B-1 Exchange Caps, and assuming the exchange of all of the shares of Series B-1 Preferred Stock owned or controlled by the Oaktree Funds for Common Shares (but not the exchange of Series B-1 Preferred Stock owned or controlled by Engaged, if any), the Oaktree Funds would collectively own approximately 22.1% of the then-outstanding Common Shares, including 17,315,893 and 3,410,233 Common Shares currently held by Organics and OHIF II LP, respectively.
This Amendment No. 10 is being filed to reflect a change in the percentage previously reported, based on the outstanding number of Common Shares reported by the Issuer in the 10-Q.
The Reporting Person has no other material changes to the information previously reported or transactions within the prior 60 days to disclose. Neither the filing of this Statement nor any of its contents shall be deemed to constitute an admission by any of the Reporting Persons that such person is the beneficial owner of any of the Common Shares referred to herein for purposes of the Act, or for any other purpose.
Item 7. | Material to be Filed as Exhibits |
| | |
Exhibit 99.1 | | Joint Filing Agreement, dated May 17, 2023, among the Reporting Persons. |